Literature DB >> 28646357

Management of Hyperglycemia and Diabetes in the Emergency Department.

Justin B Echouffo-Tcheugui1, Rajesh Garg2.   

Abstract

PURPOSE OF REVIEW: Hyperglycemia in the emergency department (ED) is being recognized as a public health problem and presents a clinical challenge. This review critically summarizes available evidence on the burden, etiology, diagnosis, and practical management strategies for hyperglycemia in the ED. RECENT
FINDINGS: Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) are hyperglycemic emergencies that commonly present to the ED. However, the most common form of hyperglycemia in ED is associated with non-hyperglycemic medical emergencies. The presence of hyperglycemia increases the mortality and morbidity associated with the primary condition. The related hospital admission rates and costs are also elevated. The frequency of DKA or HHS related mortality and morbidity has remained high over the last decade. However, attempts have been made to improve management of all hyperglycemia in the ED. Evidence suggests that better management of hyperglycemia in the ED with proper follow-up improves clinical outcomes and prevents readmission. Optimization of the hyperglycemia management in the ED may improve clinical outcomes. However, more clinical trial data on the outcomes and cost-effectiveness of various management strategies or protocols are needed.

Entities:  

Keywords:  Diabetes; Diabetic ketoacidosis; Emergency department; Hyperglycemia; Hyperglycemic hyperosmolar state

Mesh:

Year:  2017        PMID: 28646357     DOI: 10.1007/s11892-017-0883-2

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  49 in total

1.  Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.

Authors:  Elisa Hsia; Stacey Seggelke; Joanna Gibbs; R Matthew Hawkins; Elizabeth Cohlmia; Neda Rasouli; Cecilia Wang; Igal Kam; Boris Draznin
Journal:  J Clin Endocrinol Metab       Date:  2012-06-08       Impact factor: 5.958

2.  Hyperglycemic crises in urban blacks.

Authors:  G E Umpierrez; J P Kelly; J E Navarrete; M M Casals; A E Kitabchi
Journal:  Arch Intern Med       Date:  1997-03-24

3.  Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.

Authors:  Guillermo E Umpierrez; Kashif Latif; James Stoever; Ruben Cuervo; Linda Park; Amado X Freire; Abbas E Kitabchi
Journal:  Am J Med       Date:  2004-09-01       Impact factor: 4.965

4.  Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population.

Authors:  Adit A Ginde; Enrico Cagliero; David M Nathan; Carlos A Camargo
Journal:  J Gen Intern Med       Date:  2008-06-10       Impact factor: 5.128

5.  Role of glucagon and other hormones in development of diabetic ketoacidosis.

Authors:  K G Alberti
Journal:  Lancet       Date:  1975-06-14       Impact factor: 79.321

6.  Phosphate therapy in diabetic ketoacidosis.

Authors:  H K Wilson; S P Keuer; A S Lea; A E Boyd; G Eknoyan
Journal:  Arch Intern Med       Date:  1982-03

7.  A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis.

Authors:  J N Fisher; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

8.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012.

Authors:  Andy Menke; Sarah Casagrande; Linda Geiss; Catherine C Cowie
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

9.  Hyperglycemia in emergency patients--prevalence and consequences: results of the GLUCEMERGE analysis.

Authors:  Edin Zelihic; Boris Poneleit; Thorsten Siegmund; Bernhard Haller; Friedhelm Sayk; Christoph Dodt
Journal:  Eur J Emerg Med       Date:  2015-06       Impact factor: 2.799

10.  Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.

Authors:  Michelle A Charfen; Eli Ipp; Amy H Kaji; Tawny Saleh; Mohammed F Qazi; Roger J Lewis
Journal:  Acad Emerg Med       Date:  2009-03-16       Impact factor: 3.451

View more
  5 in total

1.  Initiating Insulin in the Emergency Center and Urgent Care to Prevent Hospital Admission for Patients with Hyperglycemia: A Unique Insulin Starter Kit.

Authors:  Janet L Davidson; Richard M Bergenstal; Jessica A Conry; Ruth Taswell; Anders L Carlson
Journal:  J Diabetes Sci Technol       Date:  2021-04-10

2.  Combination of endothelial progenitor cells and BB-94 significantly alleviates brain damage in a mouse model of diabetic ischemic stroke.

Authors:  Daixuan Zhou; Zhi Huang; Xiaoxi Zhu; Tao Hong; Yuanli Zhao
Journal:  Exp Ther Med       Date:  2021-05-21       Impact factor: 2.447

3.  Gossypol from Cottonseeds Ameliorates Glucose Uptake by Mimicking Insulin Signaling and Improves Glucose Homeostasis in Mice with Streptozotocin-Induced Diabetes.

Authors:  Md Badrul Alam; Hongyan An; Jeong-Sic Ra; Ji-Young Lim; Seung-Hyun Lee; Chi-Yeol Yoo; Sang-Han Lee
Journal:  Oxid Med Cell Longev       Date:  2018-10-28       Impact factor: 6.543

4.  Terpenoid-Rich Extract of Dillenia indica L. Bark Displays Antidiabetic Action in Insulin-Resistant C2C12 Cells and STZ-Induced Diabetic Mice by Attenuation of Oxidative Stress.

Authors:  Bo-Rim Song; Md Badrul Alam; Sang-Han Lee
Journal:  Antioxidants (Basel)       Date:  2022-06-23

5.  Halophila beccarii extract ameliorate glucose uptake in 3T3-L1 adipocyte cells and improves glucose homeostasis in streptozotocin-induced diabetic rats.

Authors:  Vani Mathakala; Muni Kesavulu Muppuru; Uma Maheswari Devi Palempalli
Journal:  Heliyon       Date:  2022-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.